, Tracking Stock Market Picks
Enter Symbol:
Alnylam Pharmaceuticals, Inc. (ALNY) [hlAlert]

up 473.85 %

Alnylam Pharmaceuticals, Inc. (ALNY) rated Buy with price target $120 by Needham

Posted on: Monday,  Nov 17, 2014  9:25 AM ET by Needham

Needham rated Buy Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on 11/17/2014. Previously Needham rated Buy Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) on 07/16/2012.,
when the stock price was $18.28. Since then, Alnylam Pharmaceuticals, Inc. has gained 473.85% as of 01/22/2016's recent price of $104.90.
If you would have followed the previous Needham's recommendation on ALNY, you would have gained 473.85% of your investment in 1285 days.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is applying its therapeutic expertise in RNAi to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. Alnylam is building a pipeline of RNAi therapeutics; its lead program is in Phase I human clinical trials for the treatment of respiratory syncytial virus infection, which is the leading cause of hospitalization in infants in the U.S. The company's leadership position in fundamental patents, technology, and know-how relating to RNAi has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, and Biogen Idec.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2014 9:25 AM Buy
90.15 120.00
as of 10/17/2014
1 Week up  18.29 %
1 Month up  10.92 %
3 Months up  65.66 %
1 YTD up  34.02 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/14/2014 8:25 AM Buy
78.72 84.00
8/9/2013 8:25 AM Buy
49.00 55.00
7/1/2013 3:25 PM Buy
32.83 40.00
7/16/2012 2:25 PM Buy
18.28 20.00
2/25/2009 8:25 AM Hold
3/3/2008 8:25 AM Sell
8/13/2007 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy